These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 31376822)
1. Differences in Kynurenine Metabolism During Depressive, Manic, and Euthymic Phases of Bipolar Affective Disorder. Maget A; Platzer M; Bengesser SA; Fellendorf FT; Birner A; Queissner R; Hamm C; Reininghaus B; Hecker A; Tomberger L; Pilz R; Dalkner N; Moll N; Schütze G; Schwarz M; Kapfhammer HP; Reininghaus EZ Curr Top Med Chem; 2020; 20(15):1344-1352. PubMed ID: 31376822 [TBL] [Abstract][Full Text] [Related]
2. A mood state-specific interaction between kynurenine metabolism and inflammation is present in bipolar disorder. van den Ameele S; van Nuijs AL; Lai FY; Schuermans J; Verkerk R; van Diermen L; Coppens V; Fransen E; de Boer P; Timmers M; Sabbe B; Morrens M Bipolar Disord; 2020 Feb; 22(1):59-69. PubMed ID: 31398273 [TBL] [Abstract][Full Text] [Related]
3. Increased breakdown of kynurenine towards its neurotoxic branch in bipolar disorder. Birner A; Platzer M; Bengesser SA; Dalkner N; Fellendorf FT; Queissner R; Pilz R; Rauch P; Maget A; Hamm C; Herzog-Eberhard S; Mangge H; Fuchs D; Moll N; Zelzer S; Schütze G; Schwarz M; Reininghaus B; Kapfhammer HP; Reininghaus EZ PLoS One; 2017; 12(2):e0172699. PubMed ID: 28241062 [TBL] [Abstract][Full Text] [Related]
7. Differential mitochondrial DNA copy number in three mood states of bipolar disorder. Wang D; Li Z; Liu W; Zhou J; Ma X; Tang J; Chen X BMC Psychiatry; 2018 May; 18(1):149. PubMed ID: 29801445 [TBL] [Abstract][Full Text] [Related]
8. Total sleep time and kynurenine metabolism associated with mood symptom severity in bipolar disorder. Mukherjee D; Krishnamurthy VB; Millett CE; Reider A; Can A; Groer M; Fuchs D; Postolache TT; Saunders EFH Bipolar Disord; 2018 Feb; 20(1):27-34. PubMed ID: 28833866 [TBL] [Abstract][Full Text] [Related]
9. Activation of kynurenine pathway in ex vivo fibroblasts from patients with bipolar disorder or schizophrenia: cytokine challenge increases production of 3-hydroxykynurenine. Johansson AS; Owe-Larsson B; Asp L; Kocki T; Adler M; Hetta J; Gardner R; Lundkvist GB; Urbanska EM; Karlsson H J Psychiatr Res; 2013 Nov; 47(11):1815-23. PubMed ID: 24012176 [TBL] [Abstract][Full Text] [Related]
11. Behavioral and Self-reported Data Collected From Smartphones for the Assessment of Depressive and Manic Symptoms in Patients With Bipolar Disorder: Prospective Observational Study. Dominiak M; Kaczmarek-Majer K; Antosik-Wójcińska AZ; Opara KR; Olwert A; Radziszewska W; Hryniewicz O; Święcicki Ł; Wojnar M; Mierzejewski P J Med Internet Res; 2022 Jan; 24(1):e28647. PubMed ID: 34874015 [TBL] [Abstract][Full Text] [Related]
13. Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. Brietzke E; Stertz L; Fernandes BS; Kauer-Sant'anna M; Mascarenhas M; Escosteguy Vargas A; Chies JA; Kapczinski F J Affect Disord; 2009 Aug; 116(3):214-7. PubMed ID: 19251324 [TBL] [Abstract][Full Text] [Related]
14. Cytokines, brain-derived neurotrophic factor and C-reactive protein in bipolar I disorder - Results from a prospective study. Jacoby AS; Munkholm K; Vinberg M; Pedersen BK; Kessing LV J Affect Disord; 2016 Jun; 197():167-74. PubMed ID: 26994434 [TBL] [Abstract][Full Text] [Related]
15. The relationship between inflammatory state and quantity of affective episodes in bipolar disorder. Queissner R; Pilz R; Dalkner N; Birner A; Bengesser SA; Platzer M; Fellendorf FT; Kainzbauer N; Herzog-Eberhard S; Hamm C; Reininghaus B; Zelzer S; Mangge H; Mansur RB; McIntyre RS; Kapfhammer HP; Reininghaus EZ Psychoneuroendocrinology; 2018 Apr; 90():61-67. PubMed ID: 29433074 [TBL] [Abstract][Full Text] [Related]
16. Neuroprotective kynurenine metabolite indices are abnormally reduced and positively associated with hippocampal and amygdalar volume in bipolar disorder. Savitz J; Dantzer R; Wurfel BE; Victor TA; Ford BN; Bodurka J; Bellgowan PS; Teague TK; Drevets WC Psychoneuroendocrinology; 2015 Feb; 52():200-11. PubMed ID: 25486577 [TBL] [Abstract][Full Text] [Related]
17. The impact of electroconvulsive therapy on the tryptophan-kynurenine metabolic pathway. Guloksuz S; Arts B; Walter S; Drukker M; Rodriguez L; Myint AM; Schwarz MJ; Ponds R; van Os J; Kenis G; Rutten BP Brain Behav Immun; 2015 Aug; 48():48-52. PubMed ID: 25765557 [TBL] [Abstract][Full Text] [Related]
18. Kynurenines: from the perspective of major psychiatric disorders. Myint AM FEBS J; 2012 Apr; 279(8):1375-85. PubMed ID: 22404766 [TBL] [Abstract][Full Text] [Related]
19. Soluble Intracellular Adhesion Molecule-1 in Patients with Unipolar or Bipolar Affective Disorders: Results from a Pilot Trial. Schaefer M; Sarkar S; Schwarz M; Friebe A Neuropsychobiology; 2016; 74(1):8-14. PubMed ID: 27442531 [TBL] [Abstract][Full Text] [Related]
20. Role of Kynurenine pathway and its metabolites in mood disorders: A systematic review and meta-analysis of clinical studies. Arnone D; Saraykar S; Salem H; Teixeira AL; Dantzer R; Selvaraj S Neurosci Biobehav Rev; 2018 Sep; 92():477-485. PubMed ID: 29940237 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]